Details for New Drug Application (NDA): 019777

✉ Email this page to a colleague

NDA 019777 describes ZESTRIL, which is a drug marketed by Twi Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the ZESTRIL profile page.

The generic ingredient in ZESTRIL is lisinopril. There are twenty-one drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the lisinopril profile page.

Summary for 019777

Tradename:	ZESTRIL
Applicant:	Twi Pharms
Ingredient:	lisinopril
Patents:	0

Pharmacology for NDA: 019777

Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Medical Subject Heading (MeSH) Categories for 019777

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiotonic Agents

Suppliers and Packaging for NDA: 019777

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ZESTRIL	lisinopril	TABLET;ORAL	019777	NDA	TWi Pharmaceuticals, Inc.	24979-238	24979-238-07	90 TABLET in 1 BOTTLE (24979-238-07)
ZESTRIL	lisinopril	TABLET;ORAL	019777	NDA	TWi Pharmaceuticals, Inc.	24979-239	24979-239-07	90 TABLET in 1 BOTTLE (24979-239-07)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	May 19, 1988	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	10MG
Approval Date:	May 19, 1988	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	20MG
Approval Date:	May 19, 1988	TE:	AB	RLD:	Yes

Expired US Patents for NDA 019777

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Twi Pharms	ZESTRIL	lisinopril	TABLET;ORAL	019777-006	Jan 20, 1999	4,374,829*PED	⤷ Subscribe
Twi Pharms	ZESTRIL	lisinopril	TABLET;ORAL	019777-005	Apr 29, 1993	4,374,829*PED	⤷ Subscribe
Twi Pharms	ZESTRIL	lisinopril	TABLET;ORAL	019777-004	May 19, 1988	4,374,829*PED	⤷ Subscribe
Twi Pharms	ZESTRIL	lisinopril	TABLET;ORAL	019777-003	May 19, 1988	4,374,829*PED	⤷ Subscribe
Twi Pharms	ZESTRIL	lisinopril	TABLET;ORAL	019777-002	May 19, 1988	4,374,829*PED	⤷ Subscribe
Twi Pharms	ZESTRIL	lisinopril	TABLET;ORAL	019777-001	May 19, 1988	4,374,829*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.